The platform, named RadGLO, extracts genetic insights from MRI images. Doctors can now plan personalized treatments for glioma patients without surgery. The study was published in Precision Oncology in October 2025.

The team also introduced RaSPr (Radiomic Survival Predictor). It sorts patients into high-risk and low-risk groups based on MRI features. Doctors can now predict tumour aggressiveness, treatment response, and survival outcomes faster and more safely.

RadGLO links MRI features to 20,000 genes, providing insights into the tumour’s molecular profile. Doctors upload scans, receive automated risk predictions, and access genetic correlations. The platform enables accurate, personalized treatment planning. The research team included Kavita Kundal, Dr. K. Divya Rani, Vinodini D, Dr. Neeraj Kumar, and Dr. Rahul Kumar.

The post IIT Hyderabad Develops AI Tool for Brain Tumour Diagnosis appeared first on India Podcast.

According to scientists involved in the study, patients who received the vaccine demonstrated stronger immune responses and, in some cases, a reduction in tumor size. Unlike traditional treatments such as chemotherapy and radiation, which can have severe side effects, the vaccine approach aims to train the body’s own defense system to fight cancer more precisely.

Experts, however, have urged cautious optimism. They stress that while the initial findings are promising, the vaccine remains in its early stages of development. Large-scale clinical trials will be required to determine its effectiveness across different cancer types and patient groups. They also warn that many treatments that succeed in small studies fail to produce the same results when tested on larger populations.

Cancer specialists see the vaccine as part of a growing trend in immunotherapy, a field that has already produced significant advances in cancer care. If successful, such vaccines could become a powerful tool alongside existing therapies, potentially improving survival rates and quality of life for patients.

For now, researchers are preparing for the next phase of trials and will continue monitoring patients for long-term effects. While there is genuine excitement within the medical community, experts emphasize the importance of realistic expectations, reminding the public that developing a safe and effective cancer vaccine could take several more years.

The post New Cancer Vaccine Brings Hope, Experts Cautious appeared first on India Podcast.